SUMMARY

Physician (MD), AI engineer (M.S. and B.S. in Electrical Engineering), and management consultant with expertise in business development and product leadership.

Specialized in driving disruptive technologies within healthcare and life sciences, delivering impactful solutions.

Extensive experience leading multidisciplinary teams, collaborating with digital health startups, investors, healthcare payers, and large organizations.

Education

University of Oxford (United Kingdom)

Doctor of Medicine (MD)

Graduated 2018

University of the Witwatersrand (South Africa)

M.S. Engineering (with Distinction)

Graduated 2012

B.S. Electrical Engineering (EE)

Graduated 2010

Experience

Multinational, publicly-traded healthcare insurer/payer, best known internationally for its Vitality Program.
(40 international markets; 2023 revenue of $4.5B)

Discovery Health

Head of Product, Pathology | Head of Business Development, Pathology

January 2022 -July 2022

  • Led pathology BD at global firm (JSE:DSY) with > $4.5B revenue (2023), executed major acquisition, built top partnerships, and disrupted a $700M market.

  • Expanded market footprint and revenue by forging key alliances and driving tech innovations.

  • Pioneered an analytics-driven IT platform that boosted operational efficiency and streamlined clinical guidelines to enhance care quality and efficiency.

  • Unified diverse teams to ensure compliance across legal, clinical, and financial domains while managing supplier relations and conducting rigorous health tech assessments.

  • Enabled rapid deployment of new practices in high-impact areas, culminating in a smooth transition from concept to board approval and successful implementation.

BD and Product Lead, Digital Biomarkers

April 2021 - December 2021

  • Headed AI initiatives, achieving up to 75% cost savings, 100% increase in user engagements, and led multidisciplinary teams through broad healthcare and wellness projects.

  • Spearheaded development and implementation of groundbreaking AI-enhanced healthcare programs, significantly improving patient care and outcomes.

  • Introduced scalable programs leveraging cutting-edge technologies and evidence-based practices, setting new industry standards.

  • Negotiated with global suppliers, achieving up to 75% cost reductions, maximizing profitability, and improving resource allocation.

  • Designed and implemented sales and marketing strategies, doubling clinician engagement and patient product adoption.

  • Formed close partnerships with healthcare thought leaders, facilitating seamless operational flows to enhance patient and clinician journeys.

Product Manager, Retinal Imaging and AI

August 2020 - March 2021

  • Championed AI/ML adoption and reimbursement in healthcare, enhancing data practices, risk strategies, and validating tech for clinical efficacy.

  • Identified and bridged critical gaps in clinical research, securing vital data to inform reimbursement decisions.

  • Collaborated with data scientists, clinicians, and regulatory experts to refine data collection protocols and develop predictive models for health risk mitigation.

  • Crafted thorough evaluations of clinical evidence, setting benchmarks for assessing technology's effectiveness, safety, and economic impact.

  • Reported to the C-suite, translating complex clinical and technical requirements into actionable strategies.

  • Fostered partnerships with medical societies and aligned technology adoption with international regulatory standards.

Boutique consultancy dedicated to modernizing public healthcare infrastructure and technology, improving patient outcomes through strategic partnerships and innovative solutions.

Outreach Innovations

Chief Product Officer | Chief Business Development Officer

June 2013 - June 2021

  • Directed the organization's exponential growth over eight years, fostering a culture of excellence and adaptability, and enhancing team performance through strategic leadership.

  • Forged alliances with government bodies and industry leaders, navigating complex bureaucratic ecosystems and securing CSR investments to stabilize public healthcare infrastructure.

  • Led high-stakes negotiations with hospital boards and corporate sponsors, presenting comprehensive tech solutions that showcased projected impact and ROI, resulting in successful project approvals and funding.

  • Pivoted strategic focus in response to sudden leadership changes at partner hospitals, securing a new deal with a larger hospital, and ensuring the survival and growth of the business.

  • Revolutionized South Africa's largest public hospitals by spearheading infrastructural upgrades, reducing elective procedure waiting times, and improving clinician working conditions and patient outcomes.

  • Implemented cutting-edge technologies in major hospitals, enhancing operational efficiency and service delivery, and delivering significant improvements in patient care metrics.

  • Championed community health initiatives, such as building a permanent outdoor gym at a local orphanage during COVID-19.

University of California, San Francisco (UCSF)

Visiting scholar - Department of Surgical Innovations

April 2018 - August 2018

  • Pioneered surgical solutions for type 2 diabetes by designing innovative surgical devices and creating collaborations to support growth.

  • Performed bench assessments, analyzed preclinical designs, and completed cadaver studies to validate approaches.

  • Identified and partnered with key figures in the technology sector, such as IBM, to integrate advanced technologies into solutions.

  • Contributed to the organization's strategy, business development, and preparation for fundraising.

  • Utilized business expertise to guide the commercialization strategy, and ensure a comprehensive approach to growth and innovation.

Johns Hopkins University

Visiting scholar - Center for Systems Science and Engineering

August 2022 - Present

February 2018 - April 2018

  • Bridged communication gaps between diverse teams, leading to innovative solutions in public health and healthcare.

  • Synthesized complex information to enhance collaboration among project managers, engineers, and medical professionals.

  • Contributed significantly to system dynamics models, shedding light on intricate public health issues.

  • Conducted research instrumental in developing policies for healthy food ordinances and autonomous vehicle testing.

  • Developed strategies to mitigate hospital-acquired infections.

  • Co-authored several groundbreaking papers on environmental interventions to curb the spread of pathogenic bacteria in healthcare settings.

  • Collaborated on a computational tool recognized as a finalist in the prestigious Johns Hopkins Healthcare Design Competition.

Boutique health, wellness, and life science innovation consultancy, specializing in product and business development, focusing on genAI, AI/ML, precision health, digital biomarkers, medical devices (incl. SaMD), and pharma/life science innovations.

InnovaHealth.AI

Chief Growth and Product Officer (Product and Business Development for HCLS)

  • Leveraged healthcare industry, AI and clinical expertise to capitalize on emerging trends, delivering 100x growth opportunities to businesses and investors.

  • Influenced cross-functional teams by distilling and articulating complex clinical and technical data into engaging narratives, enhancing investor relations and driving successful product launches.

  • Developed 0-to-1 product roadmaps for next-generation digital health services, building market-leading innovations, identifying industry trends, and pioneering computer-vision and AI-enabled medical devices.

  • Designed novel AI/ML models and digital biomarkers for healthcare analytics, using multimodal data to predict and quantify chronic disease risk and progression rates, enabling delivery of personalized, precision medicine.

  • Engineered an advanced RPM solution integrating AI-driven algorithms, significantly improving chronic disease management, reducing hospital admissions, and increasing patient outcomes.

  • Forged key partnerships and developed go-to-market strategies, pivoting D2C models to B2B and/or B2B2C models, securing major retailer contracts, and significantly boosting revenue and market presence.

Involvement

World Congress on Interventional Therapies for Type 2 Diabetes (WCITD) - New York City

April 2019

Expert panelist

  • Provided specialist engineering and clinical guidance as part of a panel of regulatory environment experts, tasked with defining evidence requirements for novel surgical procedures and clinical products before these can be used clinically to provide patient care.

  • Established ethical and scientific criteria to assess novel devices and procedures prior to clinical adoption, defined innovation in the context of product development for medicine and surgery, and co-authored a document that provides detailed guidelines for all surgical procedure and device innovators.

  • Introduced steps to guide innovation of medical products through the development of product concepts, prototyping, clinical validation studies and randomized controlled trials, and regulatory approvals.

IEEE AFRICON (IEEE's flagship conference in Africa)

Subject matter expert and reviewer

June 2017

  • Assessed conference submissions relevant to the healthcare space for validity, quality and originality, to ensure that scientific concepts and clinical content were appropriate, tradeoffs were clearly outlined, and technology capabilities were suitably advanced.

  • Evaluated the clinical opportunities, clinical requirements, and project deliverables for each submission, and delivered accept/reject recommendations to the conference chair.

  • Provided clear and courteous feedback to investigators and authors, to ensure that conference presentations and posters met rigorous scientific standards.